<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD06950000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P07858</UniProt_ID>
  <Seq_Length>339</Seq_Length>
  <Molecule_Weight>37822</Molecule_Weight>
  <KEGG_ID>hsa:1508</KEGG_ID>
  <Orthology_ID>K01363</Orthology_ID>
  <EBI_ID>EBI-715062</EBI_ID>
  <Function_Summary>Thiol protease which is believed to participate in intracellular degradation and turnover of proteins. Has also been implicated in tumor invasion and metastasis.</Function_Summary>
  <Catalytic_Mechanism>Hydrolysis of proteins with broad specificity for peptide bonds. Preferentially cleaves -Arg-Arg-|-Xaa bonds in small molecule substrates (thus differing from cathepsin L). In addition to being an endopeptidase, shows peptidyl-dipeptidase activity, liberating C-terminal dipeptides.</Catalytic_Mechanism>
  <Pfam_ID>PF00112:Peptidase_C1@@PF08127:Propeptide_C1</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>APPS</Alias>
      <Alias>Cathepsin B light chain</Alias>
      <Alias>Cathepsin B1</Alias>
      <Alias>Cathepsin B heavy chain</Alias>
      <Alias>APP secretase</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a mechanism in which the sulfhydryl group of a cysteine residue at the active center acts as a nucleophile.</Detail>
      <Keyword>Cysteine-type endopeptidase activity</Keyword>
      <Ontology_ID>GO:0004197</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.</Detail>
      <Keyword>Hydrolase activity</Keyword>
      <Ontology_ID>GO:0016787</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of peptide bonds in a polypeptide chain by a mechanism in which the sulfhydryl group of a cysteine residue at the active center acts as a nucleophile.</Detail>
      <Keyword>Cysteine-type peptidase activity</Keyword>
      <Ontology_ID>GO:0008234</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid.</Detail>
      <Keyword>Peptidase activity</Keyword>
      <Ontology_ID>GO:0008233</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>235</Position>
      <Original>Ser</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>53</Position>
      <Original>Ser</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>91</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>26</Position>
      <Original>Leu</Original>
      <Variation>Val</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any process that modulates the activity of an enzyme.</Detail>
      <Keyword>Regulation of catalytic activity</Keyword>
      <Ontology_ID>GO:0050790</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.</Detail>
      <Keyword>Proteolysis</Keyword>
      <Ontology_ID>GO:0006508</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.</Detail>
      <Keyword>Innate immune response</Keyword>
      <Ontology_ID>GO:0045087</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the occurrence or rate of cell death by apoptosis.</Detail>
      <Keyword>Regulation of apoptosis</Keyword>
      <Ontology_ID>GO:0042981</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <Molecule_Seq>
    <Protein_Seq>MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTDQYWEKI</Protein_Seq>
    <DNA_Seq>GGGGCGGGGCCGGGAGGGTACTTAGGGCCGGGGCTGGCCCAGGCTACGGCGGCTGCAGGGCTCCGGCAACCGCTCCGGCAACGCCAACCGCTCCGCTGCGCGCAGGCTGGGCTGCAGGCTCTCGGCTGCAGCGCTGGGTGGATCTAGGATCCGGCTTCCAACATGTGGCAGCTCTGGGCCTCCCTCTGCTGCCTGCTGGTGTTGGCCAATGCCCGGAGCAGGCCCTCTTTCCATCCCCTGTCGGATGAGCTGGTCAACTATGTCAACAAACGGAATACCACGTGGCAGGCCGGGCACAACTTCTACAACGTGGACATGAGCTACTTGAAGAGGCTATGTGGTACCTTCCTGGGTGGGCCCAAGCCACCCCAGAGAGTTATGTTTACCGAGGACCTGAAGCTGCCTGCAAGCTTCGATGCACGGGAACAATGGCCACAGTGTCCCACCATCAAAGAGATCAGAGACCAGGGCTCCTGTGGCTCCTGCTGGGCCTTCGGGGCTGTGGAAGCCATCTCTGACCGGATCTGCATCCACACCAATGCGCACGTCAGCGTGGAGGTGTCGGCGGAGGACCTGCTCACATGCTGTGGCAGCATGTGTGGGGACGGCTGTAATGGTGGCTATCCTGCTGAAGCTTGGAACTTCTGGACAAGAAAAGGCCTGGTTTCTGGTGGCCTCTATGAATCCCATGTAGGGTGCAGACCGTACTCCATCCCTCCCTGTGAGCACCACGTCAACGGCTCCCGGCCCCCATGCACGGGGGAGGGAGATACCCCCAAGTGTAGCAAGATCTGTGAGCCTGGCTACAGCCCGACCTACAAACAGGACAAGCACTACGGATACAATTCCTACAGCGTCTCCAATAGCGAGAAGGACATCATGGCCGAGATCTACAAAAACGGCCCCGTGGAGGGAGCTTTCTCTGTGTATTCGGACTTCCTGCTCTACAAGTCAGGAGTGTACCAACACGTCACCGGAGAGATGATGGGTGGCCATGCCATCCGCATCCTGGGCTGGGGAGTGGAGAATGGCACACCCTACTGGCTGGTTGCCAACTCCTGGAACACTGACTGGGGTGACAATGGCTTCTTTAAAATACTCAGAGGACAGGATCACTGTGGAATCGAATCAGAAGTGGTGGCTGGAATTCCACGCACCGATCAGTACTGGGAAAAGATCTAATCTGCCGTGGGCCTGTCGTGCCAGTCCTGGGGGCGAGATCGGGGTAGAAATGCATTTTATTCTTTAAGTTCACGTAAGATACAAGTTTCAGACAGGGTCTGAAGGACTGGATTGGCCAAACATCAGACCTGTCTTCCAAGGAGACCAAGTCCTGGCTACATCCCAGCCTGTGGTTACAGTGCAGACAGGCCATGTGAGCCACCGCTGCCAGCACAGAGCGTCCTTCCCCCTGTAGACTAGTGCCGTAGGGAGTACCTGCTGCCCCAGCTGACTGTGGCCCCCTCCGTGATCCATCCATCTCCAGGGAGCAAGACAGAGACGCAGGAATGGAAAGCGGAGTTCCTAACAGGATGAAAGTTCCCCCATCAGTTCCCCCAGTACCTCCAAGCAAGTAGCTTTCCACATTTGTCACAGAAATCAGAGGAGAGACGGTGTTGGGAGCCCTTTGGAGAACGCCAGTCTCCCAGGCCCCCTGCATCTATCGAGTTTGCAATGTCACAACCTCTCTGATCTTGTGCTCAGCATGATTCTTTAATAGAAGTTTTATTTTTTCGTGCACTCTGCTAATCATGTGGGTGAGCCAGTGGAACAGCGGGAGACCTGTGCTAGTTTTACAGATTGCCTCCTTATGACGCGGCTCAAAAGGAAACCAAGTGGTCAGGAGTTGTTTCTGACCCACTGATCTCTACTACCACAAGGAAAATAGTTTAGGAGAAACCAGCTTTTACTGTTTTTGAAAAATTACAGCTTCACCCTGTCAAGTTAACAAGGAATGCCTGTGCCAATAAAAGTTTTCTCCAACTTGAAGTCTACTCTGATGGGATCTCAGATCCTTTGTCACTGCCTATAGACTTGTAGCTGCTGTCTCTCTTTGTCCCTGCAGAGAATCACGTCCTGGAACTGCATGTTCTTGCGACTCTTGGGACTTCATCTTAACTTCTCGCTGCCCCAGCCATGTTTTCAACCATGGCATCCCTCCCCCAATTAGTTCCCTGTCATCCTCGTCAACCTTCTCTGTAAGTGCCTGGTAAGCTTGCCCTTGCTTAAGAACTCAAAACATAGCTGTGCTCTATTTTTTTGTTGTTGTTGTGACTGACAGAGTGAGATTCCGTCTCCCAGGCTGGAGTGCAGTGGCGCCTTCTCAGCTCACTGCAACCTGCAGCCTCCTAGATTCAAGCGATTCTCCTGCTTCAGCCTTCCGAGTAGCTGGGATGACAGGCACTCACCAATATGCCTGGGTAATTTTTGTATTTTTAAGTACATACAGGATTTCACCATGTTGGCCAGGCTAGTTTCAAACTCCCGGCCTCAGGTGGTCTGCCTGCCTCAGCCTCCCAAAGTGTTGGGATTACAGGCGTGAGCCACTGGGCCCTGCCTGTATTTTTTATCAGCCACAAATCCAGCAACAAGCTGAGGATTCAGCTCATAAAACAGGCTTGGTGTCTTGGTGATCTCACATAACCAAGATGCTACCCCGTGGGGAACCACATCCCCCTGGATGCCCTCCAGCCTTGGTTTGGGCTGGAGTCAGGGCCTGTATACAGTATTTTGAATTTGTATGCCACTGGTTTGCATTGCTGGTCAGGAACTCTAGTGCTTTGCATAGCCCTGGTTTAGAAACATGTTATAGCAGTTCTTGGTATAGAGCAAACTAGAAGAACCAGCAATCATTCCACTGTCCTGCCAAGGTACACCTCAGTACTCCCCTTCCCAACTGAAGTGGTATGAGGCTAGCTCTTTCCAAAAGCATTCAAGTTTGGCTTCTGATGTGACTCAGAATTTAGGAACCAGATGCTAGATCAAATAAGCTCTGAAAATCTGAGGAACATTGTAGGAAAGGTTTGTTAAGCATCTCTTAAGTGCCATGATGAGCATAACAGCCGGCCGTCGTGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCCAAGGTGGGAGGATGACAAGGTCAGGAGTTCAAGACCAGCCTGGCCAACATGCTGAAACCTCACCTCTACTAAAAATACAAAAATTAGCTGGGCATGGTGGCACATGCCTGTAATCCCAGCTACTTGGGAGGCTGAGGCAGGAGAATCGCTTGAACCCGGGAGGCGGAGGTTGCAGTGAGCCAAGACAGTGCCAGTGCACTCCAGCCTCGGTGACAGCGCAAGGCTCCGTCTCAATAATTAAAAAAAAAAAAAAAAAAAAAAAGGCCGGGCGCAGTGGCTCAAGCCTGTAATCCCAGCACTTTGGGAGGCTGAGGCGGGCAGATCACCTGAGGTCAGGAGTTTTGAGATCAGCCTTGGCAACACGGTGAAACCCCATCTCTACTAAAAATACAAAATTAGCCAAGCATGCTGGCACATGCCTGTAATCCCAGCTACTCGGGAGGCTGAGGTACGAGAATCGCTTGAACCTGGGAGGCAGAGGATGCAGTGAGCCGAGATCACGCCATTGCACTCCAGCCTGGGGGACAAGAGTGAATCTGTGTCTCACCAAAAAAAAAAAGAAAAAGAAAGATGCTTAACAAAGGTTACCATAAGCCACAAATTCATAACCACTTATCCTTCCAGTTTCAAGTAGAATATATTCATAACCTCAATAAAGTTCTCCCTGCTCCCAAA</DNA_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Extracellular space</CellLocal>
      <Ontology_ID>GO:0005615</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Perinuclear region of cytoplasm</CellLocal>
      <Ontology_ID>GO:0048471</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Lysosome</CellLocal>
      <Ontology_ID>GO:0005764</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Melanosome</CellLocal>
      <Ontology_ID>GO:0042470</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>CTSB</Gene_Name>
    <Gene_Alias>CPSB</Gene_Alias>
    <Gene_ID>1508</Gene_ID>
    <Genbank_ACCN>NM_001908</Genbank_ACCN>
    <Protein_ACCN>NP_001899</Protein_ACCN>
    <HGNC_ID>2527</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/1508</Gene_URL>
    <UCSC_ID>uc003wum.3</UCSC_ID>
    <EMBL_ID>ENSG00000164733</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>P40692</Uniprot_ID>
      <Gene_Name>MLH1</Gene_Name>
      <EBI_ID>EBI-744248</EBI_ID>
      <PPI_EBI_URL>EBI-715062,EBI-744248</PPI_EBI_URL>
      <Experiment_Number>7</Experiment_Number>
    </PPI>
  </PPI_List>
  <Disease_List>
    <Disease>
      <Disease_Name>Keratoconus</Disease_Name>
      <Disease_Detail>Keratoconus</Disease_Detail>
      <Disease_DB>KRT007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/keratoconus?search=CTSB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Dementia</Disease_Name>
      <Disease_Detail>Dementia</Disease_Detail>
      <Disease_DB>DMN002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/dementia?search=CTSB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Tropical Calcific Pancreatitis</Disease_Name>
      <Disease_Detail>Tropical Calcific Pancreatitis</Disease_Detail>
      <Disease_DB>TRP008</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/tropical_calcific_pancreatitis?search=CTSB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Occlusion of Gallbladder</Disease_Name>
      <Disease_Detail>Occlusion of Gallbladder</Disease_Detail>
      <Disease_DB>OCC004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/occlusion_of_gallbladder?search=CTSB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Gingival Overgrowth</Disease_Name>
      <Disease_Detail>Gingival Overgrowth</Disease_Detail>
      <Disease_DB>GNG012</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/gingival_overgrowth?search=CTSB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pancreatitis</Disease_Name>
      <Disease_Detail>Pancreatitis</Disease_Detail>
      <Disease_DB>PNC044</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pancreatitis?search=CTSB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Meningioma</Disease_Name>
      <Disease_Detail>Meningioma</Disease_Detail>
      <Disease_DB>MNN012</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/meningioma?search=CTSB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Keratolytic Winter Erythema</Disease_Name>
      <Disease_Detail>Keratolytic Winter Erythema</Disease_Detail>
      <Disease_DB>KRT013</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/keratolytic_winter_erythema?search=CTSB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hereditary Pancreatitis</Disease_Name>
      <Disease_Detail>Hereditary Pancreatitis</Disease_Detail>
      <Disease_DB>HRD057</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hereditary_pancreatitis?search=CTSB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Mucolipidosis Ii</Disease_Name>
      <Disease_Detail>Mucolipidosis Ii</Disease_Detail>
      <Disease_DB>MCL015</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/mucolipidosis_ii?search=CTSB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Benign Meningioma</Disease_Name>
      <Disease_Detail>Benign Meningioma</Disease_Detail>
      <Disease_DB>BNG002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/benign_meningioma?search=CTSB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Alzheimer's Disease</Disease_Name>
      <Disease_Detail>Alzheimer's Disease</Disease_Detail>
      <Disease_DB>ALZ001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/alzheimers_disease?search=CTSB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Amyloidosis, Secondary</Disease_Name>
      <Disease_Detail>Amyloidosis</Disease_Detail>
      <Disease_DB>AMY053</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/amyloidosis_secondary?search=CTSB#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Adenocarcinoma</Disease_Name>
      <Disease_Detail>Adenocarcinoma</Disease_Detail>
      <Disease_DB>ADN016</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/adenocarcinoma?search=CTSB#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Crystal structure of cathepsin b inhibited with CA030 at 2.1 angstroms resolution: A basis for the design of specific epoxysuccinyl inhibitors</PDB_Title>
      <PDB_ID>1CSB</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1CSB</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of cathepsin B inhibited with CA030 at 2.0-A resolution: A basis for the design of specific epoxysuccinyl inhibitors.</PubMed_Title>
      <Author>Turk, D., et al.</Author>
      <Journal>Biochemistry(1995)34:4791-4797</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/7718586?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>REFINED CRYSTAL STRUCTURE OF HUMAN PROCATHEPSIN B AT 2.5 ANGSTROM RESOLUTION</PDB_Title>
      <PDB_ID>3PBH</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3PBH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of the wild-type human procathepsin B at 2.5 A resolution reveals the native active site of a papain-like cysteine protease zymogen.</PubMed_Title>
      <Author>Podobnik, M., et al.</Author>
      <Journal>J.Mol.Biol.(1997)271:774-788</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9299326?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>chagasin-cathepsin B</PDB_Title>
      <PDB_ID>3CBK</PDB_ID>
      <Resolution>2.67</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3CBK</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Displacement of the occluding loop by the parasite protein, chagasin, results in efficient inhibition of human cathepsin B</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>CATHEPSIN B COMPLEXED WITH DIPEPTIDYL NITRILE INHIBITOR</PDB_Title>
      <PDB_ID>1GMY</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1GMY</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Identification of Dipeptidyl Nitriles as Potent and Selective Inhibitors of Cathepsin B Through Structure-Based Drug Design</PubMed_Title>
      <Author>Greenspan, P.D., et al.</Author>
      <Journal>J.Med.Chem.(2001)44:4524</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/11741472?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Cathepsin B in complex with the nitroxoline</PDB_Title>
      <PDB_ID>3AI8</PDB_ID>
      <Resolution>2.11</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3AI8</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Novel Mechanism of Cathepsin B Inhibition by Antibiotic Nitroxoline and Related Compounds</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF HUMAN PROCATHEPSIN B AT 3.3 ANGSTROM RESOLUTION</PDB_Title>
      <PDB_ID>2PBH</PDB_ID>
      <Resolution>3.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2PBH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structures of human procathepsin B at 3.2 and 3.3 Angstroms resolution reveal an interaction motif between a papain-like cysteine protease and its propeptide.</PubMed_Title>
      <Author>Turk, D., et al.</Author>
      <Journal>FEBS Lett.(1996)384:211-214</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/8617355?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>THE REFINED 2.15 ANGSTROMS X-RAY CRYSTAL STRUCTURE OF HUMAN LIVER CATHEPSIN B: THE STRUCTURAL BASIS FOR ITS SPECIFICITY</PDB_Title>
      <PDB_ID>1HUC</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1HUC</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The refined 2.15 A X-ray crystal structure of human liver cathepsin B: the structural basis for its specificity.</PubMed_Title>
      <Author>Musil, D., et al.</Author>
      <Journal>EMBO J.(1991)10:2321-2330</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/1868826?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF HUMAN RECOMBINANT PROCATHEPSIN B AT 3.2 ANGSTROM RESOLUTION</PDB_Title>
      <PDB_ID>1PBH</PDB_ID>
      <Resolution>3.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1PBH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structures of human procathepsin B at 3.2 and 3.3 Angstroms resolution reveal an interaction motif between a papain-like cysteine protease and its propeptide.</PubMed_Title>
      <Author>Turk, D., et al.</Author>
      <Journal>FEBS Lett.(1996)384:211-214</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/8617355?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of the tetragonal form of human liver cathepsin B</PDB_Title>
      <PDB_ID>2IPP</PDB_ID>
      <Resolution>2.15</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2IPP</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal Structure of the tetragonal form of human liver cathepsin B</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Cathepsin B in complex with stefin A</PDB_Title>
      <PDB_ID>3K9M</PDB_ID>
      <Resolution>2.61</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3K9M</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Stefin A displaces the occluding loop of cathepsin B only by as much as required to bind to the active site cleft</PubMed_Title>
      <Author>Renko, M., et al.</Author>
      <Journal>Febs J.(2010)277:4338-4345</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20860624?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Chagasin-Cathepsin B complex</PDB_Title>
      <PDB_ID>3CBJ</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3CBJ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Displacement of the occluding loop by the parasite protein, chagasin, results in efficient inhibition of human cathepsin B</PubMed_Title>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko04612</Pathway_ID>
      <Pathway_Title>Antigen processing and presentation</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Immune system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04612</Pathway_ID>
      <Pathway_Title>Antigen processing and presentation</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Immune system</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>Alpha and beta proteins (a+b)</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.e.d.b.b.bd.html</SCOP_URL>
    <CATH_Class>Class 3: Mixed Alpha-Beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1csb</CATH_URL>
  </Fold>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>3.4.22.1</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC3/4/22/1.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Create_Date>2012-06-20</Create_Date>
</Organism_Record>